Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 81Colorectal Neoplasms 72Rectal Neoplasms 47Colonic Neoplasms 25Pancreatic Neoplasms 24Neoplasm Metastasis 17Carcinoma, Hepatocellular 17Esophageal Neoplasms 11Cholangiocarcinoma 9Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Liver Neoplasms 7Biliary Tract Neoplasms 6Colorectal Cancer Metastatic 5Carcinoma, Non-Small-Cell Lung 5Recurrence 4Lymphoma, Extranodal NK-T-Cell 4Gallbladder Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Locally Advanced Rectal Cancer 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Adenocarcinoma 3Solid Tumors 2Solid Tumor 2Ovarian Neoplasms 2Neurotoxicity Syndromes 2Lymphoma 2Lung Neoplasms 2Locally Advanced Colon Cancer 2

Interventions

surufatinib 2regorafenib 2Oxaliplatin 2Irinotecan 2Fluorouracil 2Drug Therapy 2Bevacizumab 2raltitrexed 1nimotuzumab 1endostar protein 1aflibercept 1Folfox protocol 1Cetuximab 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Advanced Colorectal Cancer × Oxaliplatin × Clear all
NCT03126071 2021-08-30

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Jiangsu Cancer Institute & Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT04337879 2020-07-21

A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Unknown
56 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡